UCB raises stake in Wilex to 18.05%

Thursday 10 June 2010

UCB SA of Belgium has raised its stake in the German biopharmaceutical company, Wilex AG, to 18.05% from 11.4% following the purchase of a block of shares from a fund managed by Apax Partners. The transaction was reported on 10 June 2010.

Full text available to subscribers only. Click here for information on subscribing to MedNous.

Location

Belgium